Logo-ijhpm
Int J Health Policy Manag. 2022;11(4): 470-478. doi: 10.34172/ijhpm.2020.169
PMID: 33059424        PMCID: PMC9309953

Original Article

Impact of the Requirement of Bone Mineral Density Evidence on Utilization of Anti-osteoporosis Medications, Clinical Outcome and Medical Expenditures of Patient With Hip Fracture in Taiwan

Chen-Yu Wang 1,2,3 ORCID, Shau-Huai Fu 4, Chih-Chien Hung 4, Rong-Sen Yang 5, Jou-Wei Lin 6, Ho-Min Chen 7, Fei-Yuan Hsiao 1,2,8 * ORCID, Li-Jiuan Shen 1,2,8 * ORCID

Cited by CrossRef:

1- Hsu C, Sung S, Yang H, Huang W, Hsieh C. Utilization of screening and treatment for osteoporosis among stroke survivors. Front Endocrinol. 2022;13 [Crossref]